Quality is now in the front. It is the incoming wave.
Continue reading “Regulatory update: quality and risk management in clinical trials – the next wave”
Quality is now in the front. It is the incoming wave.
Continue reading “Regulatory update: quality and risk management in clinical trials – the next wave”
Research â but especially methods research â can be particularly dry & technical â and critically, impenetrable to folks that arenât doing the work themselves. Weâve seen how language plays a role in gate-keeping our diverse communities from understanding whatâs happening in methods research, and we decided to do something about it.
Continue reading “4 reasons to write in plain language and why itâs easier than you think”
Question: What drugs issued from our pharmacy need to have drug accountability records retained for a clinical trial? Continue reading “ASK JEAN: Pharmacy Records in Clinical Trials – Drug Accountability Records”
“Patients, those with lived experience, are the best judges of their welfare, period. And so, their voices must be heard; and, make an impact in health research.” BC Academic Health Science Network President, and the Methods Clusters’ first Scientific Director, Dr. Stirling Bryan, on how his health economist training took him deep into #POR methods.
Continue reading “Patient-oriented research needs health economics because?”
REACH BC is the newest addition to the organization. Continue reading “REACH BC platform joins the BC Academic Health Science Network”
We are one year into the pandemic. The inefficiencies of our health care system are more obvious than ever. Read our latest post from Dr. Danielle Lavallee, BC AHSN Scientific Director, discussing changing health care on the fly, opportunities for data, and how disruptions COVID-19 has brought to our healthcare system can change it for the better.
Continue reading “The pandemic is forcing us to improve health care. My thoughts on how.”
Research Ethics BC is pleased to announce that three new partners have joined the provincial network.
We interviewed Dr. McMaster virtually to chat about his role in creating Clinical Trials BC and its predecessor, and the vital role that he played in leading the operational unitâs advisory council.
Sarah Bennett, REBC Advisory Councilâs outgoing and inaugural Chair, concluded her term in January 2021. Continue reading “Thanking Sarah Bennett, REBCâs Inaugural Advisory Council Chair”
The #1 question we get about the Methods Clusters is âWhat are the Methods Clusters?â We’re bringing you answers to this and more in our new blog: the Methods Section. Weâre looking forward to peeling back the curtain a little to share with you perspectives from individuals involved in the Methods Clusters.